Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer is a research paper published in Journal of Clinical Investigation (2022). On theSindex it has a DataRank of 1.9. It has been cited 79 times, with 53 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.657
From this paper's citation signal
Citation Network Contribution
1.3
From 49 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 53 citers.
National Institutes of Health
Grant: Intramural funding
Merck KGaA
Grant: Cooperative Research
Merck KGaA
Grant: Development Agreement
MeSH Terms
Keywords